Numerous practice guidelines recommend multicomponent, evidence-based nutritional and behavioral therapy for adults with obesity, but use of such therapies with GLP-1s is not widespread
At Skindale Medspa, our GLP-1 weight loss program involves using FDA-approved medications, such as semaglutide, that mimic the action of this hormone to help you achieve and maintain your weight loss goals
To maximize the benefits and ensure safety, close collaboration with healthcare providers is crucial
The manufacturer, Eli Lilly Co., has submitted orforglipron to the FDA for approval for use in weight management, with a decision expected in the second quarter of 2026
GLP-1 RAs have numerous pharmacological effects on the management of T2DM
This issue troubled scientists for years